Decided not to accept the offer & bought another batch of shares at 1.29 today.

If the privatisation fail, the share prices will up another 50% easily cos FGV is the most undervalued plantation stock. If the privatisation go through with Felda manages to own more than 90%, they still oblige to buy back the balance 10% share with the same offer price from us. The offer period normally will be extended for this purpose.

Quoted the following from CGS-CIMB startegy note dated 5th Jan 2021:

"Interestingly, FGV emerged as the top buy list of foreign investors last week after FELDA's takeover offer for FGV at RM1.30 per share became unconditional."

Now we know who are the main buyers after the privitisation news.

Wait for the good show on the fight between felda and foregn investors on the privitisation. Dont forget the CPO now stands above RM4k for both Jan & Feb future contract.

Mr Tan - My stock picks for 2021 as follows:-

1) FLBHD - 5%
2) HOHUP - 30%
3) KOSSAN - 30%
4) MSM - 5%
5) RUBEREX - 30%

TQ

Nothing to reveal. It is about TSL increased his stake yesterday due to late annoucements.

Coming QR should be very good. Result will be out this week

India rushes to cover Q1 soy oil, Su oil shorts amid Argentine strike

https://www.reuters.com/article/argentina-grains-strike-idUSL1N2J119F

https://www.brecorder.com/news/40043976

https://www.agricensus.com/Article/India-rushes-to-cover-Q1-soyoil-sunoil-shorts-amid-Argentine-strikes-14815.html

India rushes to cover Q1 soy oil, Su oil shorts amid Argentine strike

https://www.reuters.com/article/argentina-grains-strike-idUSL1N2J119F

https://www.brecorder.com/news/40043976

https://www.agricensus.com/Article/India-rushes-to-cover-Q1-soyoil-sunoil-shorts-amid-Argentine-strikes-14815.html

Many local & foreign instituitions are holding this share counter at a loss even at 1.30 offer price. That's the reason Felda very hard to achieve 90% holding.


Question now is who is buying FGV at 1.28 now? Could it be Felda? Syed Mokhtar? Or other GLICs? If not Felda, very likely we can get a higher return than 1.30.


No one will buy at 1.28 & sell to Felda at 1.30 to earn a return lesser than FD rate after minus the tranx costs. The answer will reveal soon in 1 week's time.

So, why desperate to sell now to earn the 0.1% interest?

For 1.30, investors who invested before year 2019 wont accept the offer. Somemore the CPO price is so high now. This will reflect in the coming QR.

There is no way to achieve 90% acquistion for the delisting.

I believe the revised offer price would be around 1.78 (40% upside). For the 9.9b sukuk issued, 6b used to reduce debt. The balance 3.9 b will be used for acquistition of FGV & terminate the land lease agreement.

After minus 658m for the share purchased from KWAP & UJSB, balance is 3,242m to be divided by balance of 50% publicly holding share (1,820m).

Hold tight to your shares & wait for increase of the offer price. No way to delist with current offer price. The ultimate objective of Felda is to terminate the land lease agreement & take control back on the land use.

10% return is guaranteed if MGO materialised. If not, then we can expect a higher return with current CPO price. This share is pressed down by the mgo news.

Look here. Why only LWC is buying & not other Top 3 bosses? Is he only the smart one? Or only his company the most under value? Or only TopGlov holds too much of cash?

When you become one of the richest, own pride comes first before money & the company.
Pls spend the money wisely to improve the accommodation quality of the staff.

Should also investigate Top Glove management who gives lots of misleading statement to investors, for eg:
a) resolve FDA matters by Nov 20,
b) Factory will be back to operation after 14 DAYS (only) after quaratine of its workers in the press statement given,
c) potential replace MBB as TOP 1 in KLSE by early Oct 20
DLL...

SC should instead investigate local IBs which give high unachievable TP with conflict interest by issuing CWs.

MBB, CIMB & RHB has used ESG as an excuse to revise downwards the TP. Assess the target price by using normal P/E ratio in this extraordinary time is inappropriate. Another few good examples are Genting, GenM & Airport. They have ridiculously high PE but they all are good buy now to reap the good returns in another 2 - 3 years.

Yes, good yield for next few years. But do expect a big capital loss after that!

Food index prices rose in October for fifth straight month. Prices of American grain is surging, & so CPO due to:

1. Dry weather from La Nina is interfering with planting of in Brazil
2.China ban on imports of Australian crops, e.g. barley, wheat
3. Russia government is mulling a quota ban on wheat exports

My prediction is more prudent, gross profit around 11m. Good enough for me.

Will hold through Q4 QR for the extraordinary profit.

LLB termination will happen only after 18 months the earliest if it materialized. How many long term investors here?

IOI mentioned in its QR result that CPO price will maintain above 3000 till Feb 21.

In addtional, FGV has no labor shortage issue. The estates are owned by settlers.

All IBs are not given enough attention to plantation stocks. Market is more efficient & reacts better to current CPO price than all these ‘analysts’.

Soon they will change their tune following market movements.

Finished building my plantation portfolio. Last batch bought at 1.10 today. Fantastic Q3 & Q4 results are guaranteed looking at Nov & Dec future price.

That’s also the reason why Top Glove boss wanna support at current share price through share buy back, in order for him to dispose his stake in the company through listing in HK, just like how he disposed 5% of his shareholding via secondary listing in Sinagapore back in 2016.

The share price dropped right after the secondary listing in Singapore.

He got the right valuation model for glove counters at this super growth period. Just two points to add:
1) this high profit period will last at least 2 years, as backed by the order in hands till 620 days
2) the price to assets is overstated, as 50% profit will be given back to shareholders as per dividend policy.

So nett nett it’s come back to the total valuation given by Sifu, ie around 30+b

Boss mentioned no bonus issue plan for the time being, looking at the poor share price performance of its peers post bonus issued date.

AstraZeneca starts trial of COVID-19 antibody treatment

https://www.channelnewsasia.com/news/world/covid-19-coronavirus-astrazeneca-antibody-treatment-13051318

AstraZeneca starts trial of COVID-19 antibody treatment

https://www.channelnewsasia.com/news/world/covid-19-coronavirus-astrazeneca-antibody-treatment-13051318

AstraZeneca starts trial of COVID-19 antibody treatment

https://www.channelnewsasia.com/news/world/covid-19-coronavirus-astrazeneca-antibody-treatment-13051318

Just to give everyone head-up, Oxford vaccine 3rd phase trial result will be out by this month end. Vaccine will ready for emergency use by Sep this year, as per Citi research report.

(Big) funds are out from the glove counters, that’s the reason why no rotate play fr one glove counter to another glove counter. Other reasons are just noises.

Apple, better mind your own business if you have no idea what’s trigger the recent sell down of all glove stocks. Better promote more at TopGlove forum to push up the price. Majority has moved to private chat group.

Phillip sold all his top glove shares at RM14 & make millions profit. The funds reinvested in o&g sector.

Top Glov share price will drop below RM14 again? I can’t imagine.

Citi group give higher TP price for Kossan 31.20 vs Supermx 24.90.
More will come.

Fantastic quarter result doesn’t guaranteed good future share price, cos it was past & fully reflected. A good example is Supermx.

Agree with Warchest.
Profit taking by big players started even before Supermx QR result was out due to vaccine development.

Anyway, the corona cases are real, demand shortage of gloves & ASP price increase is real (new plant takes mora than 1 year to start operating), the vaccine immunity can’t last longer than 1 year is real (wonder how Russian prove the vaccine immunity can last 2 years, whereas the pandemic started only end of last year).

Why sell cheap at current price?

UG Healthcare today announced >1000% increase in half yearly net profit from S$1.2m to S$12.6m.

Lukey_Greek Apple, you think my estimation of Supermax gross profit of RM500m just plucked from the sky? What i want to tell you is that the price of supermax has fully relected the ASP as shared in the analyst briefing slide.

To get 1b net profit for next quarter, even take in add. 2.2b production from Block B of Plant no. 12, ASP still need to increase further from USD180.

If you dont believe the slides, Supermax market price has spoken itself today.

Apple, you got the hints? Let me make it clear, the Jul ASP only up 13% compared to last quarter for Supermx. In comparison, Harta increase 30% each for Jul & Aug, whereas Kossan will up 20% & 40% respectively for next 2 months.

Which counters have higher potential? & which one is fairly price now? Smart investor like you should have a better answer.

The outcome of the review of MSCI Malaysia Index will be known on 12th Aug. Hope Kossan will be upgraded from Small Cap to Large & Mid cap segment, same category with Harta & TopGlov.

Fast & furious.

Last chance for IBs to collect tickets before excellence QR result from both Supermx & UG Healthcare.


Good signs instead.

This is a very interesting week. The best of 2 OBM counters will be releasing their result:
a) 10/8 (Mon) - Supermx
b) 11/8 (Tue) - UG Healthcare

Supermx has moved forward their result announcement earlier fr 11/8 to 10/8 to avoid UG Healthcare to steal its limelight. From here we know which counter will have better performance.

Anyway, both counters will have outstanding result. Hopefully, the stock price running will follow for both 1st & 2nd tier glove stocks. Enjoy the show!

In CIMB report dated yesterday, Harta will increase 30% ASP in 3Q20, and another 30% in 4Q20. TP for Harta increased to 24.30.

Just wait for the same announcement from Kossan. No sweats to hold laggard players, cause ASP also laggard.

No impact, instead you can read it as good news.

This has nothing to do with Hextar Global. The Executive Director buy this under his own company & personal capacity.

1. Why stock price for big 4 dropped early this morning before Harta released its result?
2. Why Harta rebounded strongly after a weak result?

Its because market already knew & moved in advanced. Fund managers have been waiting for this opportunity to grab cheap tickets of Harta, in big volume.

Let the share price speak itself. Just look at the share price by this month end & year end.

The sell off is temporary, tickets are not many. Pandemic is here to stay for at least another 2 years. Demand for glove after pandemic will increase 30-40%. But glove price can’t increase another 2 or 3 folds for OBM. Manufacturing price for OEM is catching up soon & fast.

The choice is yours if you still wanna chase high on Supermx.

No one is promoting Harta here except you in your earlier posts. Mr_Kiah the first one highlighted Harta result is not good (I know also). Dont act like you know stock investment skills.

The most you know maybe the quarter profit through your previous network.

According to Hartalega CEO Kuan Mun Leong, there will be structural step-up increase in demand of 30%-40% post-pandemic period. Demand in the next few years will still be very very strong.

https://www.youtube.com/watch?v=vDhgdI4aPXI

Computation on the adjustment of CW exercise price for bonus issues

https://disclosure.bursamalaysia.com/FileAccess/apbursaweb/download?id=105154&name=EA_GA_ATTACHMENTS

Maybank top pick is Kossan while CIMB top pick is TopGlov. I will wait for the price of Kossan catching up with Supermx in the coming weeks, while someone keeps giving same stale news. How could you make same investment decision based on info available 2 months ago?

Bonus issue is definitely on the card for Kossan by this year, most likely in Aug together with Q2 result, in order to list the bonus shares and boost the market cap by this year end. It’s crucial to beat supermx market cap to guarantee to be placed as a FBM KLCI component stock by this year.

Maybank TP 19.50 & UOB 19.40. CIMB revised TP 16.40 was history.